Leerink Partners upgraded shares of Envista (NYSE:NVST – Free Report) from an underperform rating to a market perform rating in a research report released on Thursday morning, MarketBeat.com reports. They currently have $23.00 target price on the stock, up from their prior target price of $16.00.
A number of other equities research analysts have also recently issued reports on the stock. Stifel Nicolaus boosted their target price on shares of Envista from $18.00 to $21.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Evercore ISI boosted their target price on shares of Envista from $18.00 to $23.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Robert W. Baird reduced their target price on shares of Envista from $19.00 to $17.00 and set a “neutral” rating for the company in a research report on Monday, July 22nd. Piper Sandler reduced their target price on shares of Envista from $18.00 to $16.00 and set a “neutral” rating for the company in a research report on Tuesday, July 30th. Finally, Bank of America cut their price objective on shares of Envista from $22.00 to $19.00 and set a “buy” rating for the company in a research report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $20.71.
Get Our Latest Stock Report on Envista
Envista Trading Down 0.1 %
Envista (NYSE:NVST – Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.09 by $0.03. The company had revenue of $601.00 million during the quarter, compared to analysts’ expectations of $590.34 million. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. Envista’s quarterly revenue was down 4.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.43 earnings per share. Equities analysts anticipate that Envista will post 0.7 EPS for the current year.
Insiders Place Their Bets
In other Envista news, CFO Eric D. Hammes bought 24,532 shares of the stock in a transaction on Monday, August 12th. The stock was purchased at an average price of $16.33 per share, with a total value of $400,607.56. Following the completion of the purchase, the chief financial officer now owns 24,532 shares in the company, valued at $400,607.56. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.30% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the company. William Blair Investment Management LLC increased its stake in shares of Envista by 4.0% in the first quarter. William Blair Investment Management LLC now owns 14,049 shares of the company’s stock valued at $300,000 after buying an additional 538 shares during the period. GAMMA Investing LLC increased its stake in shares of Envista by 69.8% in the third quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock valued at $35,000 after buying an additional 726 shares during the period. Allspring Global Investments Holdings LLC increased its stake in shares of Envista by 50.8% in the third quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after buying an additional 728 shares during the period. Victory Capital Management Inc. increased its stake in shares of Envista by 2.3% in the second quarter. Victory Capital Management Inc. now owns 36,021 shares of the company’s stock valued at $599,000 after buying an additional 800 shares during the period. Finally, Blue Trust Inc. increased its stake in shares of Envista by 69.7% in the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock valued at $39,000 after buying an additional 804 shares during the period.
Envista Company Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Read More
- Five stocks we like better than Envista
- What is a Secondary Public Offering? What Investors Need to Know
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- Why is the Ex-Dividend Date Significant to Investors?
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- How to Invest in Insurance Companies: A Guide
- Battle of the Retailers: Who Comes Out on Top?
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.